Episodes (Page 2)
✨
Scammers exploit digital tools to supercharge old behaviors.
✨
Joel Mokyr explains how culture drives innovation, impacting economic progress.
✨
Commodity traders profit from global instability and conflict.
Jack Farchy
Javier Blas
✨
Filmmaker Werner Herzog fears sloppy thinkers and mistaking facts for truth.
✨
Existing drugs may treat rare diseases, but finding matches is difficult.
Steve Levitt
✨
Nudge theory's impact is examined years after its initial publication.
✨
Cannabis is not a performance-enhancing drug for athletes.
✨
Examining the ethics of performance-enhancing drugs in sports.
✨
Running backs' declining salaries and shorter careers.
✨
AI's long-awaited potential in the healthcare industry.
✨
Zeke Emanuel critiques the wellness industry.
✨
Steve Levitt ends his podcast 'People I (Mostly) Admire'.
✨
Marty Makary's agenda for the FDA: faster drug approvals, healthier food, and cures.
✨
Investigating the effectiveness and safety of brain supplements.
✨
An economist critiques personal finance guru advice.
✨
Behavioral science explores psychological resets for lasting change.
✨
Challenging the narrative that the wealthy are less generous.
✨
Exploring the enduring appeal of Handel's 'Messiah'.
✨
The economics of keeping 'Messiah' alive today.
✨
Handel's comeback with 'Messiah' after a career slump.